RF Neuromodulation
Platform
Radiofrequency‑based, multimodal neuromodulation platform (50–950 MHz) for Alzheimer's disease and other neurodegenerative diseases.
Multimodal Deep Neuromodulation
Advanced Technologies for Brain Health
Combining radiofrequency, photobiomodulation and gamma-frequency entrainment to modulate brain networks involved in neurodegenerative diseases
Radiofrequency Neuromodulation
Neuropod delivers controlled radiofrequency (RF) fields in the 50-950MHz range to gently stimulate deep and cortical brain networks, with parameters tuned for safety and compatibility with long-term use.
Photobiomodulation
Integrated red and and near-infrared modules enable transcranial photobiomodulation which has been reported to boost mitochondrial function, cerebral blood flow, and neuroprotection in neurodegenerative disorders.
Gamma Entrainment
Gamma-frequency stimulation (around 40 Hz) is used to entrain brain oscillations associated with memory and network synchrony, building on emerging evidence liking gamma rythms to amyloid and tau processing.
Resources
Scientific evidence informing the NeuroPod
Links for
Radiofrequency Neuromodulation
Clinical and preclinical studies show that transcranial radiofrequency neuromodulation can reduce β-amyloid and tau accumulation, and may improve cognitive performance in Alzheimer’s models.
Links for
Photobiomodulation
Red and near-infrared light therapy has been reported to modulate brain activity, support mitochondrial function and cerebral blood flow, and improve cognitive measures in neurodegenerative disorders.
Links for
Gamma entrainment
Gamma-frequency stimulation studies suggest that 40Hz entrainment can influence brain oscillatory rhythms, neuroinflammation and amyloid-beta processing, with early signals in Alzheimer's disease models and pilot trials.
Explore a curated selection of scientific studies, medical advancements, and technological innovations related to Neuropod and non-invasive brain stimulation.